136 related articles for article (PubMed ID: 35398604)
1. d-mannose administration improves autoimmune hepatitis by upregulating regulatory T cells.
Ito D; Ito H; Ideta T; Kanbe A; Shimizu M
Cell Immunol; 2022 May; 375():104517. PubMed ID: 35398604
[TBL] [Abstract][Full Text] [Related]
2. Adoptive transfer of regulatory T cells stimulated by Allogeneic Hepatic Stellate Cells mitigates liver injury in mice with concanavalin A-induced autoimmune hepatitis.
Huang H; Deng Z
Biochem Biophys Res Commun; 2019 Apr; 512(1):14-21. PubMed ID: 30853178
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Concanavalin a-Induced Murine Autoimmune Hepatitis Models.
Ye T; Wang T; Yang X; Fan X; Wen M; Shen Y; Xi X; Men R; Yang L
Cell Physiol Biochem; 2018; 46(3):1241-1251. PubMed ID: 29672295
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition of receptor-interacting protein 3 improves experimental autoimmune hepatitis].
Liu M; Zhang HX; Zhang L; Zhao JW; Zhou L; Wang BM
Zhonghua Gan Zang Bing Za Zhi; 2022 Nov; 30(11):1231-1236. PubMed ID: 36891703
[No Abstract] [Full Text] [Related]
5. Regulatory T Cells in Autoimmune Hepatitis: Unveiling Their Roles in Mouse Models and Patients.
Wang H; Feng X; Yan W; Tian D
Front Immunol; 2020; 11():575572. PubMed ID: 33117375
[TBL] [Abstract][Full Text] [Related]
6. Multi-Omics Analysis Reveals the Protection of Gasdermin D in Concanavalin A-Induced Autoimmune Hepatitis.
Wang K; Wu W; Jiang X; Xia J; Lv L; Li S; Zhuge A; Wu Z; Wang Q; Wang S; Li L
Microbiol Spectr; 2022 Oct; 10(5):e0171722. PubMed ID: 35972273
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of microRNA-155 attenuates concanavalin-A-induced autoimmune hepatitis by regulating Treg/Th17 cell differentiation.
Xia G; Wu S; Wang X; Fu M
Can J Physiol Pharmacol; 2018 Dec; 96(12):1293-1300. PubMed ID: 30290123
[TBL] [Abstract][Full Text] [Related]
8. Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+ T cell function.
Ai G; Yan W; Yu H; Xiao F; Xi D; Ma K; Huang J; Luo X; Wan X; Ning Q
J Gene Med; 2018 Jul; 20(7-8):e3023. PubMed ID: 29756667
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of Punica granatum (pomegranate) peel extract on concanavalin A-induced autoimmune hepatitis in mice.
Wang T; Men R; Hu M; Fan X; Yang X; Huang X; Ye T; Yang L
Biomed Pharmacother; 2018 Apr; 100():213-220. PubMed ID: 29428670
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells.
Hegde VL; Hegde S; Cravatt BF; Hofseth LJ; Nagarkatti M; Nagarkatti PS
Mol Pharmacol; 2008 Jul; 74(1):20-33. PubMed ID: 18388242
[TBL] [Abstract][Full Text] [Related]
11. Ability of IDO to attenuate liver injury in alpha-galactosylceramide-induced hepatitis model.
Ito H; Hoshi M; Ohtaki H; Taguchi A; Ando K; Ishikawa T; Osawa Y; Hara A; Moriwaki H; Saito K; Seishima M
J Immunol; 2010 Oct; 185(8):4554-60. PubMed ID: 20844202
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies.
Taubert R; Hardtke-Wolenski M; Noyan F; Wilms A; Baumann AK; Schlue J; Olek S; Falk CS; Manns MP; Jaeckel E
J Hepatol; 2014 Nov; 61(5):1106-14. PubMed ID: 24882050
[TBL] [Abstract][Full Text] [Related]
13. Concanavalin-A as a Model for Induction of Murine Autoimmune Hepatitis: Role of TNF-α and NF-κβ During The Acute Phase.
AboElnazar SY; Ghoneim HE; Ghazy AA; El-Shamandy MI; Kazem AH; Rashwan EK
Egypt J Immunol; 2020 Jun; 27(2):19-30. PubMed ID: 33548974
[TBL] [Abstract][Full Text] [Related]
14. Tryptophan-kynurenine profile in pediatric autoimmune hepatitis.
Lytton SD; Osiecki M; MałgorzataWoźniak ; Cukrowska B; Wierzbicka A; Goliszek M; Socha P; Janczyk W; Dayanakli D; Abendroth D; Kramp S; Fechner K; Scheper T; Mahler M; Bentow C; Bogdanos D; Fuchs D; Woynarowski M
Immunol Res; 2019 Feb; 67(1):39-47. PubMed ID: 30666511
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of KLF14 protects against immune-mediated hepatic injury in mice.
Chen X; Tan Q; Wang Y; Lv H; Wang Z; Lin Z; Du Z; Xiong S; Han J; Tian D; Wang B
Lab Invest; 2019 Jan; 99(1):37-47. PubMed ID: 30254317
[TBL] [Abstract][Full Text] [Related]
16. The JAK inhibitor tofacitinib ameliorates immune‑mediated liver injury in mice.
Wang H; Feng X; Han P; Lei Y; Xia Y; Tian D; Yan W
Mol Med Rep; 2019 Dec; 20(6):4883-4892. PubMed ID: 31638166
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune hepatitis induction can occur in the liver.
Dywicki J; Buitrago-Molina LE; Pietrek J; Lieber M; Broering R; Khera T; Schlue J; Manns MP; Wedemeyer H; Jaeckel E; Hardtke-Wolenski M
Liver Int; 2020 Feb; 40(2):377-381. PubMed ID: 31724273
[TBL] [Abstract][Full Text] [Related]
18. Diammonium Glycyrrhizinate Mitigates Liver Injury Via Inhibiting Proliferation Of NKT Cells And Promoting Proliferation Of Tregs.
Gao M; Li X; He L; Yang J; Ye X; Xiao F; Wei H
Drug Des Devel Ther; 2019; 13():3579-3589. PubMed ID: 31802846
[TBL] [Abstract][Full Text] [Related]
19. zVAD alleviates experimental autoimmune hepatitis in mice by increasing the sensitivity of macrophage to TNFR1-dependent necroptosis.
Li X; Zhang Y; Wang J; Li Y; Wang Y; Shi F; Hong L; Li L; Diao H
J Autoimmun; 2022 Dec; 133():102904. PubMed ID: 36108506
[TBL] [Abstract][Full Text] [Related]
20. Targeting Glutamine Metabolism Ameliorates Autoimmune Hepatitis
Yu Q; Tu H; Yin X; Peng C; Dou C; Yang W; Wu W; Guan X; Li J; Yan H; Zang Y; Jiang H; Xia Q
Front Immunol; 2022; 13():880262. PubMed ID: 35663990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
